1. Home
  2. ALCO vs NERV Comparison

ALCO vs NERV Comparison

Compare ALCO & NERV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Alico Inc.

ALCO

Alico Inc.

HOLD

Current Price

$37.90

Market Cap

293.7M

Sector

N/A

ML Signal

HOLD

Logo Minerva Neurosciences Inc

NERV

Minerva Neurosciences Inc

HOLD

Current Price

$7.97

Market Cap

269.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ALCO
NERV
Founded
1960
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
293.7M
269.6M
IPO Year
1994
2014

Fundamental Metrics

Financial Performance
Metric
ALCO
NERV
Price
$37.90
$7.97
Analyst Decision
Hold
Analyst Count
0
1
Target Price
N/A
$7.00
AVG Volume (30 Days)
25.3K
218.7K
Earning Date
02-04-2026
03-11-2026
Dividend Yield
0.53%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$41,175,600.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$27.61
$1.15
52 Week High
$43.20
$12.46

Technical Indicators

Market Signals
Indicator
ALCO
NERV
Relative Strength Index (RSI) 35.98 66.81
Support Level $37.14 $5.34
Resistance Level $38.40 $12.46
Average True Range (ATR) 1.41 0.71
MACD -0.25 0.03
Stochastic Oscillator 11.51 77.64

Price Performance

Historical Comparison
ALCO
NERV

About ALCO Alico Inc.

Alico Inc is a Florida-based agribusiness and land management company that mainly focuses on citrus production and grove conservation. The company operates through two primary business units: Alico Citrus and Land Management and Other Operations. The Alico Citrus segment engages in the cultivation of citrus trees and delivers citrus to the processed and fresh citrus markets. It mainly serves the processed market and sells Hamlin oranges and the Valencia variety to the orange juice processors. The Land Management and Other Operations segment engages in land leasing for recreational, conservation, and mining activities. Alico Citrus delivers the majority of the revenue as the firm's primary operating business unit.

About NERV Minerva Neurosciences Inc

Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. The company's pipeline products include MIN-101, MIN-202, and MIN-301. Targeted disorders include schizophrenia, insomnia, depressive disorder, and Parkinson's disease. Its product portfolio and potential indications include Roluperidone for the treatment of negative symptoms in patients with schizophrenia; Seltorexant, for the treatment of insomnia disorder and depressive disorder; MIN-117 for the treatment of MDD; and MIN-301 for the treatment of Parkinson's disease.

Share on Social Networks: